Literature DB >> 18382643

Phage Therapy - Everything Old is New Again.

Andrew M Kropinski1.   

Abstract

The study of bacterial viruses (bacteriophages or phages) proved pivotal in the nascence of the disciplines of molecular biology and microbial genetics, providing important information on the central processes of the bacterial cell (DNA replication, transcription and translation) and on how DNA can be transferred from one cell to another. As a result of the pioneering genetics studies and modern genomics, it is now known that phages have contributed to the evolution of the microbial cell and to its pathogenic potential. Because of their ability to transmit genes, phages have been exploited to develop cloning vector systems. They also provide a plethora of enzymes for the modern molecular biologist. Until the introduction of antibiotics, phages were used to treat bacterial infections (with variable success). Western science is now having to re-evaluate the application of phage therapy - a therapeutic modality that never went out of vogue in Eastern Europe - because of the emergence of an alarming number of antibiotic-resistant bacteria. The present article introduces the reader to phage biology, and the benefits and pitfalls of phage therapy in humans and animals.

Entities:  

Keywords:  Bacterial virus; Bacteriophage; Diagnostic tools; Human and animal studies; Novel therapies; Phage therapy; Phage typing; Phagotherapy

Year:  2006        PMID: 18382643      PMCID: PMC2095089          DOI: 10.1155/2006/329465

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  147 in total

1.  Prevention of Escherichia coli respiratory infection in broiler chickens with bacteriophage (SPR02).

Authors:  W E Huff; G R Huff; N C Rath; J M Balog; H Xie; P A Moore; A M Donoghue
Journal:  Poult Sci       Date:  2002-04       Impact factor: 3.352

Review 2.  Phage therapy: a reappraisal of bacteriophages as antibiotics.

Authors:  Jameel M Inal
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2003       Impact factor: 4.291

Review 3.  Discovering peptide ligands using epitope libraries.

Authors:  J K Scott
Journal:  Trends Biochem Sci       Date:  1992-07       Impact factor: 13.807

4.  Escherichia coli K1's capsule is a barrier to bacteriophage T7.

Authors:  Dean Scholl; Sankar Adhya; Carl Merril
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

5.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

6.  Sensitivity of various salmonella strains to felix 0-1 phage.

Authors:  L O Kallings
Journal:  Acta Pathol Microbiol Scand       Date:  1967

7.  Genetic evolution of bacteriophage. I. Hybrids between unrelated bacteriophages P22 and Fels 2.

Authors:  N Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1969-01       Impact factor: 11.205

8.  Partial purification and some properties of phi C2(W) lysin, a lytic enzyme produced by phage-infected cells of Streptococcus lactis C2.

Authors:  W M Mullan; R J Crawford
Journal:  J Dairy Res       Date:  1985-02       Impact factor: 1.904

9.  Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus.

Authors:  Michelle L Embleton; Sean P Nair; Wendy Heywood; Dev C Menon; Barry D Cookson; Michael Wilson
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

10.  Phage integrases for the construction and manipulation of transgenic mammals.

Authors:  Roger P Hollis; Stephanie M Stoll; Christopher R Sclimenti; Jennifer Lin; Yanru Chen-Tsai; Michele P Calos
Journal:  Reprod Biol Endocrinol       Date:  2003-11-07       Impact factor: 5.211

View more
  24 in total

1.  Isolation and characterization of a novel bacteriophage φ4D lytic against Enterococcus faecalis strains.

Authors:  Sylwia Parasion; Magdalena Kwiatek; Lidia Mizak; Romuald Gryko; Michał Bartoszcze; Janusz Kocik
Journal:  Curr Microbiol       Date:  2012-06-06       Impact factor: 2.188

2.  Selection and characterization of a multivalent Salmonella phage and its production in a nonpathogenic Escherichia coli strain.

Authors:  S B Santos; E Fernandes; C M Carvalho; S Sillankorva; V N Krylov; E A Pleteneva; O V Shaburova; A Nicolau; E C Ferreira; J Azeredo
Journal:  Appl Environ Microbiol       Date:  2010-09-03       Impact factor: 4.792

3.  A Tailspike with Exopolysaccharide Depolymerase Activity from a New Providencia stuartii Phage Makes Multidrug-Resistant Bacteria Susceptible to Serum-Mediated Killing.

Authors:  Hugo Oliveira; Graça Pinto; Bruna Mendes; Oscar Dias; Hanne Hendrix; Ergun Akturk; Jean-Paul Noben; Jan Gawor; Małgorzata Łobocka; Rob Lavigne; Joana Azeredo
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

4.  Beyond antibiotics?

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

Review 5.  Bacteriophages and Lysins in Biofilm Control.

Authors:  Marzanna Łusiak-Szelachowska; Beata Weber-Dąbrowska; Andrzej Górski
Journal:  Virol Sin       Date:  2020-03-03       Impact factor: 4.327

6.  Phage Therapy: Future Inquiries.

Authors:  Sijia Wu; Elisabeth Zachary; Keenan Wells; Catherine Loc-Carrillo
Journal:  Postdoc J       Date:  2013-06

7.  Complete genome sequence of Cronobacter sakazakii bacteriophage vB_CsaM_GAP161.

Authors:  Reza Abbasifar; Andrew M Kropinski; Parviz M Sabour; Hans-Wolfgang Ackermann; Erika J Lingohr; Mansel W Griffiths
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

8.  Orally administered P22 phage tailspike protein reduces salmonella colonization in chickens: prospects of a novel therapy against bacterial infections.

Authors:  Shakeeba Waseh; Pejman Hanifi-Moghaddam; Russell Coleman; Michael Masotti; Shannon Ryan; Mary Foss; Roger MacKenzie; Matthew Henry; Christine M Szymanski; Jamshid Tanha
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

9.  Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions.

Authors:  Karlene H Lynch; Kimberley D Seed; Paul Stothard; Jonathan J Dennis
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

10.  Characterization of AmiBA2446, a novel bacteriolytic enzyme active against Bacillus species.

Authors:  Krunal K Mehta; Elena E Paskaleva; Saba Azizi-Ghannad; Daniel J Ley; Martin A Page; Jonathan S Dordick; Ravi S Kane
Journal:  Appl Environ Microbiol       Date:  2013-07-19       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.